TRAF6 and Sepsis: In summary, we identify the correlation between inhibition of platelet activation and amelioration of intestinal barrier dysfunction during sepsis, which is associated with the suppression of CD40L-CD40-TRAF6 signaling pathway and the reduction of EGC activation.